Item 2.02. Results of Operations and Financial Condition

On May 15, 2023, Acer Therapeutics Inc. filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2023 and announced the results of operations in a press release. A copy of the press release announcing the results is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit
  No.                                      Description


99.1         Press release issued by Acer Therapeutics Inc. on May 15, 2023.

104        Cover page interactive data file (embedded within the inline XBRL document).







                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses